WEDNESDAY, June 30 (HealthDay News) -- Research on both mice and
frozen human heart tissue has turned up evidence that a key enzyme
involved in fetal heart development may also help trigger the onset
of a serious heart disease in adulthood.
The disease -- called cardiac hypertrophy -- is a dangerous
enlargement of the heart marked by scarring (fibrosis) caused by
cardiac stress, such as high blood pressure.
Such enlargement can lead to heart failure. But the research
team from the Stanford University School of Medicine, led by Dr.
Ching-Pin Chang, an assistant professor of cardiovascular medicine,
believe they may have found a new target that may one day help
treat the problem -- an enzyme known as "Brg1."
The finding is reported in the July 1 issue of
Nature.
The authors noted that when active in the fetal hearts of mice,
this enzyme serves to properly control heart muscle cell growth and
differentiation, a function that is normally supposed to subside
with age.
However, they found that when Brg1 is abnormally re-activated in
mice by adult cardiac stress, a cellular process gets underway that
reignites the fetal genes that normally would remain silent in
adult hearts, in turn prompting troublesome heart enlargement.
"When the Brg1 gene is deleted, the stressed adult mouse heart has only minimal pathological changes," Chang noted in a news release. "It does not have significant hypertrophy. Theres no fibrosis or scarring."
This convinced Chang and his colleagues that Brg1 may indeed
play an important role in heart enlargement disease -- a notion
that was further reinforced by work with human heart tissue that
had been frozen by the Stanford Cardiovascular Genomics and
Proteomics Tissue Bank.
Working with tissue taken from four heart patients who had
experienced heart enlargement as well as samples from six healthy
patients, the researchers found that activation of Brg1 was linked
to the disease. In addition, the greater the enzyme's activity, the
more severe the disease.
"We hope to develop a chemical inhibitor that can target Brg1 activity in hypertrophic hearts and treat this disease," said Chang.
More information
For more on cardiac hypertrophy visit
American Heart Association.